[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.207.116. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
April 27, 2005

Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial—Correction

JAMA. 2005;293(16):1978. doi:10.1001/jama.293.16.1978-c

Incorrect data: In the Original Contribution entitled “Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial” published in the April 6, 2005, issue of JAMA (2005;293:1617-1625), incorrect data were reported in the abstract and in Table 3. On page 1617 in the “Results” section of the abstract, “Compared with placebo, 380 mg of long-acting naltrexone resulted in a 25% decrease in the event rate of heavy drinking days” should have been reported as “(P = .02)” instead of “(P  = .03)” and on page 1622 in the “Heavy drinking” row in the “Naltrexone 380 mg vs Placebo” columns of Table 3, the P value should have been reported as “.02” instead of “.03.”

×